Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis

Four copper(II) complexes with chiral Schiff-base ligands, [Cu(R-L1)2]·EtOAc (1) and [Cu(S-L1)2]·EtOAc (2), [Cu(R-L2)2]·EtOAc (3) and [Cu(S-L2)2]·EtOAc (4), (R/S-HL1 = (R/S)-(1-naththyl)-salicylaldimine, R/S-HL2 = (R/S)-(1-naththyl)-3-methoxysalicylaldimine, EtOAc = ethyl acetate) were synthesized t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medicinal chemistry 2016-05, Vol.114, p.244-256
Hauptverfasser: Zhou, Xue-Quan, Li, Yang, Zhang, Dong-Yan, Nie, Yan, Li, Zong-Jin, Gu, Wen, Liu, Xin, Tian, Jin-Lei, Yan, Shi-Ping
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 256
container_issue
container_start_page 244
container_title European journal of medicinal chemistry
container_volume 114
creator Zhou, Xue-Quan
Li, Yang
Zhang, Dong-Yan
Nie, Yan
Li, Zong-Jin
Gu, Wen
Liu, Xin
Tian, Jin-Lei
Yan, Shi-Ping
description Four copper(II) complexes with chiral Schiff-base ligands, [Cu(R-L1)2]·EtOAc (1) and [Cu(S-L1)2]·EtOAc (2), [Cu(R-L2)2]·EtOAc (3) and [Cu(S-L2)2]·EtOAc (4), (R/S-HL1 = (R/S)-(1-naththyl)-salicylaldimine, R/S-HL2 = (R/S)-(1-naththyl)-3-methoxysalicylaldimine, EtOAc = ethyl acetate) were synthesized to serve as artificial nucleases and anticancer drugs. All complexes and R/S-HL1 ligands were structurally characterized by X-ray crystallography. The interaction of these complexes with CT-DNA was researched via several spectroscopy methods, which indicates that complexes bind to CT-DNA by moderate intercalation binding mode. Moreover, DNA cleavage experiments revealed that the complexes exhibited remarkable DNA cleavage activities in the presence of H2O2via the generation of hydroxyl radical. Particularly, complex 4 also could nick DNA with the production of 1O2. And all complexes exhibited excellent cytotoxicity to MDA-MB-231, A549 and Hela human cancer cells in micromole magnitude. Furthermore, complex 4 exhibited comparable cytotoxic effect to cisplatin against the proliferation of MDA-MB-231 and A549 cancer cells, as well as showed better anticancer ability to the three cancer cells than the other complexes. The results of cell cycle analysis indicated that complexes 3–4 could induce G2/M phase cell cycle arrest. Furthermore, MDA-MB-231 cells treated with 3 and 4 were subjected to apoptosis and death by generation of ROS and the activation of caspase-3. Interestingly, the chiral complexes 3 and 4 may induce cell apoptosis through extrinsic and mitochondrial intrinsic pathway, respectively. Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway. [Display omitted] •Four mononuclear copper(II) complexes with chiral Schiff-base ligands were synthesized and characterized.•These complexes exhibited excellent anticancer ability with IC50 values in micromole magnitude.•Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway.
doi_str_mv 10.1016/j.ejmech.2016.02.055
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1780511737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523416301453</els_id><sourcerecordid>1780511737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-90512956e7e97899dea8a7ae824dfcbb192a9ac22d14a08d2d16968816e722953</originalsourceid><addsrcrecordid>eNp9UU1v1DAQtRCILoV_gJCPHEhqO4kTc0DaLp9SBYfC2ZrYk61XSRzs7Kr7I_jPddi2x56eZvzePM88Qt5ylnPG5cUux92A5iYXqcqZyFlVPSMrXssmK0RVPicrJkSRVaIoz8irGHeMsUoy9pKcCalUKZVYkX8bP00YqPHD1OMtRtpCREv9SM2NC9DT64Rdly1t2rstjDZ-pJ9_ri8ur9e0daN145ZC63o3Hz8sD9T0CAfYIgUzu8P_tjnOfva3zqSKphF0-TmMLg7UdxQmP80-uviavOigj_jmHs_Jn69ffm--Z1e_vv3YrK8yU0gxZ4pVXKhKYo2qbpSyCA3UgI0obWfalisBCowQlpfAGptQKtk0PClEEhbn5P1p7hT83z3GWQ8uGux7GNHvo-Z1kyx4XdSJWp6oJvgYA3Z6Cm6AcNSc6SUIvdOnIPQShGZCpyCS7N29w74d0D6KHi6fCJ9OBEx7HhwGHY3D0aB1Ac2srXdPO9wB5mOcBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780511737</pqid></control><display><type>article</type><title>Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Zhou, Xue-Quan ; Li, Yang ; Zhang, Dong-Yan ; Nie, Yan ; Li, Zong-Jin ; Gu, Wen ; Liu, Xin ; Tian, Jin-Lei ; Yan, Shi-Ping</creator><creatorcontrib>Zhou, Xue-Quan ; Li, Yang ; Zhang, Dong-Yan ; Nie, Yan ; Li, Zong-Jin ; Gu, Wen ; Liu, Xin ; Tian, Jin-Lei ; Yan, Shi-Ping</creatorcontrib><description>Four copper(II) complexes with chiral Schiff-base ligands, [Cu(R-L1)2]·EtOAc (1) and [Cu(S-L1)2]·EtOAc (2), [Cu(R-L2)2]·EtOAc (3) and [Cu(S-L2)2]·EtOAc (4), (R/S-HL1 = (R/S)-(1-naththyl)-salicylaldimine, R/S-HL2 = (R/S)-(1-naththyl)-3-methoxysalicylaldimine, EtOAc = ethyl acetate) were synthesized to serve as artificial nucleases and anticancer drugs. All complexes and R/S-HL1 ligands were structurally characterized by X-ray crystallography. The interaction of these complexes with CT-DNA was researched via several spectroscopy methods, which indicates that complexes bind to CT-DNA by moderate intercalation binding mode. Moreover, DNA cleavage experiments revealed that the complexes exhibited remarkable DNA cleavage activities in the presence of H2O2via the generation of hydroxyl radical. Particularly, complex 4 also could nick DNA with the production of 1O2. And all complexes exhibited excellent cytotoxicity to MDA-MB-231, A549 and Hela human cancer cells in micromole magnitude. Furthermore, complex 4 exhibited comparable cytotoxic effect to cisplatin against the proliferation of MDA-MB-231 and A549 cancer cells, as well as showed better anticancer ability to the three cancer cells than the other complexes. The results of cell cycle analysis indicated that complexes 3–4 could induce G2/M phase cell cycle arrest. Furthermore, MDA-MB-231 cells treated with 3 and 4 were subjected to apoptosis and death by generation of ROS and the activation of caspase-3. Interestingly, the chiral complexes 3 and 4 may induce cell apoptosis through extrinsic and mitochondrial intrinsic pathway, respectively. Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway. [Display omitted] •Four mononuclear copper(II) complexes with chiral Schiff-base ligands were synthesized and characterized.•These complexes exhibited excellent anticancer ability with IC50 values in micromole magnitude.•Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2016.02.055</identifier><identifier>PMID: 26994692</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Animals ; Anticancer ability ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Apoptosis - drug effects ; Apoptosis mechanism ; Binding Sites - drug effects ; Cattle ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Chirality ; Copper - chemistry ; Copper - pharmacology ; Copper complexes ; Crystal structure ; Crystallography, X-Ray ; DNA - chemistry ; DNA Cleavage ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Humans ; Ligands ; Models, Molecular ; Molecular Structure ; Organometallic Compounds - chemical synthesis ; Organometallic Compounds - chemistry ; Organometallic Compounds - pharmacology ; Schiff Bases - chemical synthesis ; Schiff Bases - chemistry ; Schiff Bases - pharmacology ; Serum Albumin, Bovine - chemistry ; Structure-Activity Relationship</subject><ispartof>European journal of medicinal chemistry, 2016-05, Vol.114, p.244-256</ispartof><rights>2016 Elsevier Masson SAS</rights><rights>Copyright © 2016 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-90512956e7e97899dea8a7ae824dfcbb192a9ac22d14a08d2d16968816e722953</citedby><cites>FETCH-LOGICAL-c362t-90512956e7e97899dea8a7ae824dfcbb192a9ac22d14a08d2d16968816e722953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejmech.2016.02.055$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26994692$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Xue-Quan</creatorcontrib><creatorcontrib>Li, Yang</creatorcontrib><creatorcontrib>Zhang, Dong-Yan</creatorcontrib><creatorcontrib>Nie, Yan</creatorcontrib><creatorcontrib>Li, Zong-Jin</creatorcontrib><creatorcontrib>Gu, Wen</creatorcontrib><creatorcontrib>Liu, Xin</creatorcontrib><creatorcontrib>Tian, Jin-Lei</creatorcontrib><creatorcontrib>Yan, Shi-Ping</creatorcontrib><title>Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>Four copper(II) complexes with chiral Schiff-base ligands, [Cu(R-L1)2]·EtOAc (1) and [Cu(S-L1)2]·EtOAc (2), [Cu(R-L2)2]·EtOAc (3) and [Cu(S-L2)2]·EtOAc (4), (R/S-HL1 = (R/S)-(1-naththyl)-salicylaldimine, R/S-HL2 = (R/S)-(1-naththyl)-3-methoxysalicylaldimine, EtOAc = ethyl acetate) were synthesized to serve as artificial nucleases and anticancer drugs. All complexes and R/S-HL1 ligands were structurally characterized by X-ray crystallography. The interaction of these complexes with CT-DNA was researched via several spectroscopy methods, which indicates that complexes bind to CT-DNA by moderate intercalation binding mode. Moreover, DNA cleavage experiments revealed that the complexes exhibited remarkable DNA cleavage activities in the presence of H2O2via the generation of hydroxyl radical. Particularly, complex 4 also could nick DNA with the production of 1O2. And all complexes exhibited excellent cytotoxicity to MDA-MB-231, A549 and Hela human cancer cells in micromole magnitude. Furthermore, complex 4 exhibited comparable cytotoxic effect to cisplatin against the proliferation of MDA-MB-231 and A549 cancer cells, as well as showed better anticancer ability to the three cancer cells than the other complexes. The results of cell cycle analysis indicated that complexes 3–4 could induce G2/M phase cell cycle arrest. Furthermore, MDA-MB-231 cells treated with 3 and 4 were subjected to apoptosis and death by generation of ROS and the activation of caspase-3. Interestingly, the chiral complexes 3 and 4 may induce cell apoptosis through extrinsic and mitochondrial intrinsic pathway, respectively. Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway. [Display omitted] •Four mononuclear copper(II) complexes with chiral Schiff-base ligands were synthesized and characterized.•These complexes exhibited excellent anticancer ability with IC50 values in micromole magnitude.•Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway.</description><subject>Animals</subject><subject>Anticancer ability</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis mechanism</subject><subject>Binding Sites - drug effects</subject><subject>Cattle</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Chirality</subject><subject>Copper - chemistry</subject><subject>Copper - pharmacology</subject><subject>Copper complexes</subject><subject>Crystal structure</subject><subject>Crystallography, X-Ray</subject><subject>DNA - chemistry</subject><subject>DNA Cleavage</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Humans</subject><subject>Ligands</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Organometallic Compounds - chemical synthesis</subject><subject>Organometallic Compounds - chemistry</subject><subject>Organometallic Compounds - pharmacology</subject><subject>Schiff Bases - chemical synthesis</subject><subject>Schiff Bases - chemistry</subject><subject>Schiff Bases - pharmacology</subject><subject>Serum Albumin, Bovine - chemistry</subject><subject>Structure-Activity Relationship</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU1v1DAQtRCILoV_gJCPHEhqO4kTc0DaLp9SBYfC2ZrYk61XSRzs7Kr7I_jPddi2x56eZvzePM88Qt5ylnPG5cUux92A5iYXqcqZyFlVPSMrXssmK0RVPicrJkSRVaIoz8irGHeMsUoy9pKcCalUKZVYkX8bP00YqPHD1OMtRtpCREv9SM2NC9DT64Rdly1t2rstjDZ-pJ9_ri8ur9e0daN145ZC63o3Hz8sD9T0CAfYIgUzu8P_tjnOfva3zqSKphF0-TmMLg7UdxQmP80-uviavOigj_jmHs_Jn69ffm--Z1e_vv3YrK8yU0gxZ4pVXKhKYo2qbpSyCA3UgI0obWfalisBCowQlpfAGptQKtk0PClEEhbn5P1p7hT83z3GWQ8uGux7GNHvo-Z1kyx4XdSJWp6oJvgYA3Z6Cm6AcNSc6SUIvdOnIPQShGZCpyCS7N29w74d0D6KHi6fCJ9OBEx7HhwGHY3D0aB1Ac2srXdPO9wB5mOcBA</recordid><startdate>20160523</startdate><enddate>20160523</enddate><creator>Zhou, Xue-Quan</creator><creator>Li, Yang</creator><creator>Zhang, Dong-Yan</creator><creator>Nie, Yan</creator><creator>Li, Zong-Jin</creator><creator>Gu, Wen</creator><creator>Liu, Xin</creator><creator>Tian, Jin-Lei</creator><creator>Yan, Shi-Ping</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160523</creationdate><title>Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis</title><author>Zhou, Xue-Quan ; Li, Yang ; Zhang, Dong-Yan ; Nie, Yan ; Li, Zong-Jin ; Gu, Wen ; Liu, Xin ; Tian, Jin-Lei ; Yan, Shi-Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-90512956e7e97899dea8a7ae824dfcbb192a9ac22d14a08d2d16968816e722953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Anticancer ability</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis mechanism</topic><topic>Binding Sites - drug effects</topic><topic>Cattle</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Chirality</topic><topic>Copper - chemistry</topic><topic>Copper - pharmacology</topic><topic>Copper complexes</topic><topic>Crystal structure</topic><topic>Crystallography, X-Ray</topic><topic>DNA - chemistry</topic><topic>DNA Cleavage</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Humans</topic><topic>Ligands</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Organometallic Compounds - chemical synthesis</topic><topic>Organometallic Compounds - chemistry</topic><topic>Organometallic Compounds - pharmacology</topic><topic>Schiff Bases - chemical synthesis</topic><topic>Schiff Bases - chemistry</topic><topic>Schiff Bases - pharmacology</topic><topic>Serum Albumin, Bovine - chemistry</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Xue-Quan</creatorcontrib><creatorcontrib>Li, Yang</creatorcontrib><creatorcontrib>Zhang, Dong-Yan</creatorcontrib><creatorcontrib>Nie, Yan</creatorcontrib><creatorcontrib>Li, Zong-Jin</creatorcontrib><creatorcontrib>Gu, Wen</creatorcontrib><creatorcontrib>Liu, Xin</creatorcontrib><creatorcontrib>Tian, Jin-Lei</creatorcontrib><creatorcontrib>Yan, Shi-Ping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Xue-Quan</au><au>Li, Yang</au><au>Zhang, Dong-Yan</au><au>Nie, Yan</au><au>Li, Zong-Jin</au><au>Gu, Wen</au><au>Liu, Xin</au><au>Tian, Jin-Lei</au><au>Yan, Shi-Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2016-05-23</date><risdate>2016</risdate><volume>114</volume><spage>244</spage><epage>256</epage><pages>244-256</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><abstract>Four copper(II) complexes with chiral Schiff-base ligands, [Cu(R-L1)2]·EtOAc (1) and [Cu(S-L1)2]·EtOAc (2), [Cu(R-L2)2]·EtOAc (3) and [Cu(S-L2)2]·EtOAc (4), (R/S-HL1 = (R/S)-(1-naththyl)-salicylaldimine, R/S-HL2 = (R/S)-(1-naththyl)-3-methoxysalicylaldimine, EtOAc = ethyl acetate) were synthesized to serve as artificial nucleases and anticancer drugs. All complexes and R/S-HL1 ligands were structurally characterized by X-ray crystallography. The interaction of these complexes with CT-DNA was researched via several spectroscopy methods, which indicates that complexes bind to CT-DNA by moderate intercalation binding mode. Moreover, DNA cleavage experiments revealed that the complexes exhibited remarkable DNA cleavage activities in the presence of H2O2via the generation of hydroxyl radical. Particularly, complex 4 also could nick DNA with the production of 1O2. And all complexes exhibited excellent cytotoxicity to MDA-MB-231, A549 and Hela human cancer cells in micromole magnitude. Furthermore, complex 4 exhibited comparable cytotoxic effect to cisplatin against the proliferation of MDA-MB-231 and A549 cancer cells, as well as showed better anticancer ability to the three cancer cells than the other complexes. The results of cell cycle analysis indicated that complexes 3–4 could induce G2/M phase cell cycle arrest. Furthermore, MDA-MB-231 cells treated with 3 and 4 were subjected to apoptosis and death by generation of ROS and the activation of caspase-3. Interestingly, the chiral complexes 3 and 4 may induce cell apoptosis through extrinsic and mitochondrial intrinsic pathway, respectively. Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway. [Display omitted] •Four mononuclear copper(II) complexes with chiral Schiff-base ligands were synthesized and characterized.•These complexes exhibited excellent anticancer ability with IC50 values in micromole magnitude.•Chiral enantiomers 3 and 4 induced cancer cell apoptosis via different pathway.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>26994692</pmid><doi>10.1016/j.ejmech.2016.02.055</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2016-05, Vol.114, p.244-256
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_1780511737
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Animals
Anticancer ability
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Apoptosis - drug effects
Apoptosis mechanism
Binding Sites - drug effects
Cattle
Cell Line, Tumor
Cell Proliferation - drug effects
Chirality
Copper - chemistry
Copper - pharmacology
Copper complexes
Crystal structure
Crystallography, X-Ray
DNA - chemistry
DNA Cleavage
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Humans
Ligands
Models, Molecular
Molecular Structure
Organometallic Compounds - chemical synthesis
Organometallic Compounds - chemistry
Organometallic Compounds - pharmacology
Schiff Bases - chemical synthesis
Schiff Bases - chemistry
Schiff Bases - pharmacology
Serum Albumin, Bovine - chemistry
Structure-Activity Relationship
title Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A34%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Copper%20complexes%20based%20on%20chiral%20Schiff-base%20ligands:%20DNA/BSA%20binding%20ability,%20DNA%20cleavage%20activity,%20cytotoxicity%20and%20mechanism%20of%20apoptosis&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Zhou,%20Xue-Quan&rft.date=2016-05-23&rft.volume=114&rft.spage=244&rft.epage=256&rft.pages=244-256&rft.issn=0223-5234&rft.eissn=1768-3254&rft_id=info:doi/10.1016/j.ejmech.2016.02.055&rft_dat=%3Cproquest_cross%3E1780511737%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780511737&rft_id=info:pmid/26994692&rft_els_id=S0223523416301453&rfr_iscdi=true